Clinical implications of acellular mucin pools in resected rectal cancer with pathological complete response to neoadjuvant chemoradiation

被引:27
作者
de Campos-Lobato, L. F. [1 ]
Dietz, D. W. [1 ]
Stocchi, L. [1 ]
Vogel, J. D. [1 ]
Lavery, I. C. [1 ]
Goldblum, J. R. [2 ]
Skacel, M. [3 ]
Pelley, R. J. [4 ]
Kalady, M. F. [1 ,4 ,5 ]
机构
[1] Cleveland Clin, Inst Digest Dis, Dept Colorectal Surg, Cleveland, OH 44106 USA
[2] Cleveland Clin, Dept Anat Pathol, Cleveland, OH 44106 USA
[3] Dahl Chase Pathol Associates, Bangor, ME USA
[4] Cleveland Clin, Taussig Canc Inst, Cleveland, OH 44106 USA
[5] Cleveland Clin, Lerner Res Inst, Dept Canc Biol, Cleveland, OH 44106 USA
关键词
Rectal cancer; neoadjuvant treatment; mucin; chemotherapy; radiotherapy; surgery; tumour response; prognosis; COMBINED-MODALITY THERAPY; TOTAL MESORECTAL EXCISION; PREOPERATIVE CHEMORADIATION; COLORECTAL-CANCER; RADIATION-THERAPY; SURVIVAL; OUTCOMES; RECURRENCE; COLON;
D O I
10.1111/j.1463-1318.2010.02532.x
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Aim Approximately 20% of rectal cancers treated with neoadjuvant chemoradiation achieve a pathological complete response (pCR), which is associated with an improved oncological outcome. However, in a proportion of patients with a pCR, acellular pools of mucin are present in the surgical specimen. The aim of this study was to evaluate the clinical implications of acellular mucin pools in patients with rectal adenocarcinoma achieving a pCR after neoadjuvant chemoradiation followed by proctectomy. Method A single-centre colorectal cancer database was searched for patients with clinical Stage II and Stage III rectal adenocarcinoma who achieved a pCR (i. e. ypT0N0M0) after neoadjuvant chemoradiation followed by proctectomy between 1997 and 2007. Patients were categorized according to the presence or absence of acellular mucin pools in the resected specimen, and groups were compared. Patient demographics, tumour and treatment characteristics, and oncological outcomes were recorded. Primary outcomes were 3-year local and distant recurrences, and disease-free and overall survivals. Results Two hundred and fifty-eight patients with clinical Stage II or Stage III rectal adenocarcinoma were treated by neoadjuvant chemoradiation. Fifty-eight of these patients had a 58 pCR. Eleven of the 58 patients with a pCR had acellular mucin pools in the surgical specimen. The median follow up was 40 months. The groups were statistically similar with respect to demographics, chemoradiation regimens, distance of tumour from the anal verge, clinical stage and surgical procedure. No patient had local recurrence. Patients with acellular mucin pools had increased distant recurrence (21% vs 5%), decreased disease-free survival (79% vs 95%) and decreased overall survival (83% vs 95%) rates, although none of these differences was statistically significant. Conclusion The presence of acellular mucin pools in a proctectomy specimen with a pCR does not affect local recurrence, but may suggest a more aggressive tumour biology.
引用
收藏
页码:62 / 67
页数:6
相关论文
共 24 条
[1]  
Ahmad NR, 1997, BRIT J SURG, V84, P1445
[2]   Chemotherapy with preoperative radiotherapy in rectal cancer [J].
Bosset, Jean-Francois ;
Collette, Laurence ;
Calais, Gilles ;
Mineur, Laurent ;
Maingon, Philippe ;
Radosevic-Jelic, Ljiljana ;
Daban, Alain ;
Bardet, Etienne ;
Beny, Alexander ;
Ollier, Jean-Claude .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (11) :1114-1123
[3]   Prognostic value of pathologic complete response after neoadjuvant therapy in locally advanced rectal cancer: Long-term analysis of 566 ypcr patients [J].
Capirci, Carlo ;
Valentini, Vincenzo ;
Cionini, Luca ;
De Paoli, Antonino ;
Rodel, Claus ;
Glynne-Jones, Robert ;
Coco, Claudio ;
Romano, Mario ;
Mantello, Giovanna ;
Palazzi, Silvia ;
Mattia, Falchetti Osti ;
Friso, Maria Luisa ;
Genovesi, Domenico ;
Vidali, Cristiana ;
Gambacorta, Maria Antonietta ;
Buffoli, Alberto ;
Lupattelli, Marco ;
Favretto, Maria Silvia ;
La Torre, Giuseppe .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2008, 72 (01) :99-107
[4]  
Compton CC, 2000, ARCH PATHOL LAB MED, V124, P979
[5]   Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer [J].
Das, Prajnan ;
Skibber, John M. ;
Rodriguez-Bigas, Miguel A. ;
Feig, Barry W. ;
Chang, George J. ;
Wolff, Robert A. ;
Eng, Cathy ;
Krishnan, Sunil ;
Jarl, Nora A. ;
Crane, Christopher H. .
CANCER, 2007, 109 (09) :1750-1755
[6]   Neoadjuvant Therapy for Rectal Cancer: The Impact of Longer Interval Between Chemoradiation and Surgery [J].
de Campos-Lobato, Luiz Felipe ;
Geisler, Daniel P. ;
Moreira, Andre da Luz ;
Stocchi, Luca ;
Dietz, David ;
Kalady, Matthew F. .
JOURNAL OF GASTROINTESTINAL SURGERY, 2011, 15 (03) :444-450
[7]   Downstaging Without Complete Pathologic Response After Neoadjuvant Treatment Improves Cancer Outcomes for cIII but not cII Rectal Cancers [J].
de Campos-Lobato, Luiz Felipe ;
Stocchi, Luca ;
Moreira, Andre da Luz ;
Kalady, Matthew F. ;
Geisler, Daniel ;
Dietz, David ;
Lavery, Ian C. ;
Remzi, Feza H. ;
Fazio, Victor W. .
ANNALS OF SURGICAL ONCOLOGY, 2010, 17 (07) :1758-1766
[8]  
Edge S.B., 2010, AJCC cancer staging manual, V649
[9]   Effect of mucin production on survival in colorectal cancer: A case-control study [J].
Farhat, Mirna H. ;
Barada, Kassem A. ;
Tawil, Ayman N. ;
Itani, Doha M. ;
Hatoum, Hassan A. ;
Shamseddine, Ali I. .
WORLD JOURNAL OF GASTROENTEROLOGY, 2008, 14 (45) :6981-6985
[10]   A pathologic complete response to preoperative chemoradiation is associated with lower local recurrence and improved survival in rectal cancer patients treated by mesorectal excision [J].
García-Aguilar, J ;
de Anda, EH ;
Sirivongs, P ;
Lee, SH ;
Madoff, RD ;
Rothenberger, DA .
DISEASES OF THE COLON & RECTUM, 2003, 46 (03) :298-304